Evidence map›Paper›PMID 42268715›Full record

ArticleCell reports2026

B cell TET2 recruits OGT for nuclear TET2 and H2B O-GlcNAcylation to drive AID and BLIMP-1 expression and maturation of the antibody response.

Shili Li, Yibo Peng, Zhimin Yang, Xin Li, Zhenming Xu, Carlos E Rivera, Paolo Casali

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shili LiThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Yibo PengThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Zhimin YangThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Xin LiThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Zhenming XuThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Carlos E RiveraThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA.
Paolo CasaliThe Antibody Laboratory, Department of Microbiology, Immunology & Molecular Genetics, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA; Department of Medicine, University of Texas Long School of Medicine, UT Health Science Center, San Antonio, TX 78229, USA. Electronic address: pcasali@uthscsa.edu.

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR002645 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2018 to 2022
$20.4M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
San Antonio Biomedical Education and ResearchK12GM111726 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LECHLEITER, JAMES D, OYAJOBI, BABATUNDE OLUKAYODE · 2015 to 2024
$7.6M
Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1R01AI105813 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2014 to 2023
$4.5M
Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
Epigenetics of the autoantibody response in systemic lupusR01AI167416 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2021 to 2025
$3.6M
High Throughput DNA Sequencer: Illumina HiSeq 3000 SequencerS10OD021805 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAI, ZHAO · 2016 to 2016
$600k
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and governmentT32AI138944 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2018 to 2022
$561k
Epigenetic downregulation of the antibody response and inhibition of autoimmunityR56AI105813 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2013 to 2013
$286k
NCATS NIH HHS UL1 TR001120NCATS NIH HHS UL1 TR002645NCI NIH HHS P30 CA054174NIAID NIH HHS R01 AI045011NIAID NIH HHS R01 AI105813NIAID NIH HHS R01 AI167416NIAID NIH HHS R56 AI105813NIAID NIH HHS T32 AI138944NIGMS NIH HHS K12 GM111726NIH HHS S10 OD021805
6 · The paper itself

Abstract

Maturation of antibody responses entails B cell Aicda/AID and Prdm1/BLIMP-1 expression for SHM/CSR, plasma cell differentiation, and production of class-switched high-affinity antibodies. We determined that TET1, TET2, and TET3 are not expressed in resting naïve B lymphocytes, and only TET2 is induced in differentiating B cells for AID and BLIMP-1 expression. B cell TET2 recruits OGT, a metabolic sensor and sole protein O-GlcNAcylator, for O-GlcNAcylation of itself and chromatin H2B-S112. TET2 O-GlcNAcylation supports TET2-mediated active DNA demethylation (5mC oxidation to 5hmC) of Aicda and Prdm1 loci. This, together with these loci H2B-S112 O-GlcNAcylation, promotes Aicda/AID and Prdm1/BLIMP-1 expression for maturation of T-dependent and T-independent antibody responses. TET2 recruits OGT through its C-terminal-end, as evidenced by Tet2

Indexed as

Antibody FormationB-LymphocytesCell NucleusCytidine DeaminaseDNA-Binding ProteinsHistonesN-AcetylglucosaminyltransferasesPositive Regulatory Domain I-Binding Factor 1Proto-Oncogene ProteinsAnimalsCell DifferentiationDioxygenasesHumansMiceMice, Inbred C57BLCytidine DeaminaseDioxygenasesDNA-Binding ProteinsHistonesN-AcetylglucosaminyltransferasesOgt protein, mousePositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseProto-Oncogene ProteinsTet2 protein, mouseactive DNA demthylationAIDantibodyBLIMP-1class-switch DNA recombinationCP: immunologyOGTplasma cell differentiationprotein O-GlcNAcylationsomatic hypermutationTET2

Identifiers

PMID42268715
PMCPMC13387492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.